UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High endemicity of Q fever in French Guiana: A cross sectional study (2007-2017)

PLoS neglected tropical diseases, 2022-05, Vol.16 (5), p.e0010349-e0010349

2022

Volltextzugriff (PDF)

How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study

BMC medical education, 2020-10, Vol.20 (1), p.397-397, Article 397

2020

Volltextzugriff (PDF)

History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic

Microorganisms (Basel), 2021-12, Vol.9 (12), p.2491

2021

Volltextzugriff (PDF)

Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections

Journal of antimicrobial chemotherapy, 2022-03, Vol.77 (4), p.1036-1040

2022

Volltextzugriff (PDF)

Experience abroad and participation in ESCMID educational activities: results from a survey among French infectious diseases specialists in training

Clinical microbiology and infection, 2020-03, Vol.26 (3), p.388-390

2020

Volltextzugriff (PDF)

HIV pre-exposure prophylaxis (PrEP) knowledge among general practitioners in 2020: A French survey

Infectious Diseases Now, 2023-04, Vol.53 (3), p.104649-104649, Article 104649

2023

Volltextzugriff (PDF)

Prosthetic Joint Infections due to Candida Species: A Multicenter International Study

Clinical infectious diseases, 2024-08

2024

Volltextzugriff (PDF)

Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats

Infection, genetics and evolution, 2021-09, Vol.93, p.104916, Article 104916

2021

Volltextzugriff (PDF)

Accuracy of endobronchial ultrasound-guided transbronchial needle aspiration in HIV-infected patients with thoracic lymphadenopathy in a tuberculosis low-burden area

Scientific reports, 2020-10, Vol.10 (1), p.16250-16250, Article 16250

2020

Volltextzugriff (PDF)

Dalbavancin as salvage therapy in difficult-to-treat patients for diabetes-related foot osteomyelitis

Infectious Diseases Now, 2024-02, Vol.54 (1), p.104835-104835, Article 104835

2024

Volltextzugriff (PDF)

Correction to: Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions

Current tropical medicine reports, 2023-09

2023

Volltextzugriff (PDF)

Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions

Current tropical medicine reports, 2021, Vol.8 (3), p.173-182

2021

Volltextzugriff (PDF)

The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey

Infectious diseases now (Online), 2021-03, Vol.51 (2), p.215-217

2021

Volltextzugriff (PDF)

PROSTHETIC JOINT INFECTIONS DUE TO CANDIDA SPP.: A MULTICENTRE INTERNATIONAL OBSERVATIONAL STUDY

Orthopaedic Proceedings, 2023-11, Vol.105-B (SUPP_17), p.3-3

2023

Volltextzugriff (PDF)

Dual HER2 blockade with pertuzumab

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.311

2022

Volltextzugriff (PDF)

Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958)

Breast cancer research and treatment, 2022-11, Vol.196 (2), p.311-321

2022

Volltextzugriff (PDF)

Abstract P2-13-16: Dual HER2-blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T. Results from a German non-interventional study (NIS) HELENA (NCT01777958)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-16

2022

Volltextzugriff (PDF)

RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Clinical cancer research, 2023-11, Vol.29 (22), p.4606-4612

2023

Volltextzugriff (PDF)

Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer: ADAPTcycle

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS609-TPS609

2022

Volltextzugriff (PDF)

Abstract GS3-01: Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer - First results of the GeparX study

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.GS3-01-GS3-01

2020

Volltextzugriff (PDF)

Abstract PO3-18-10: Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO3-18-10-PO3-18-10

2024

Volltextzugriff (PDF)

Abstract LBO1-05: Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.LBO1-05-LBO1-05

2024

Volltextzugriff (PDF)

Abstract PO1-02-13: Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA)

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO1-02-13-PO1-02-13

2024

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

High endemicity of Q fever in French Guiana: A cross sectional study (2007-2017)

How and why do French medical students choose the specialty of infectious and tropical diseases? A national cross-sectional study

History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic

Rifabutin versus rifampicin bactericidal and antibiofilm activities against clinical strains of Staphylococcus spp. isolated from bone and joint infections

Experience abroad and participation in ESCMID educational activities: results from a survey among French infectious diseases specialists in training

HIV pre-exposure prophylaxis (PrEP) knowledge among general practitioners in 2020: A French survey

Prosthetic Joint Infections due to Candida Species: A Multicenter International Study

Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats

Accuracy of endobronchial ultrasound-guided transbronchial needle aspiration in HIV-infected patients with thoracic lymphadenopathy in a tuberculosis low-burden area

Dalbavancin as salvage therapy in difficult-to-treat patients for diabetes-related foot osteomyelitis

Correction to: Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions

Human Q Fever on the Guiana Shield and Brazil: Recent Findings and Remaining Questions

The role of infectious disease trainees during the first wave of the COVID-19 pandemic: A national survey

PROSTHETIC JOINT INFECTIONS DUE TO CANDIDA SPP.: A MULTICENTRE INTERNATIONAL OBSERVATIONAL STUDY

Dual HER2 blockade with pertuzumab

Dual HER2 blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T: results from a German non-interventional study (NIS) HELENA (NCT01777958)

Abstract P2-13-16: Dual HER2-blockade with pertuzumab (P) and trastuzumab (T) in patients with HER2-positive metastatic breast cancer (mBC) relapsing after adjuvant treatment with T. Results from a German non-interventional study (NIS) HELENA (NCT01777958)

RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Adjuvant dynamic marker-adjusted personalized therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk HR+/HER2- early breast cancer: ADAPTcycle

Abstract GS3-01: Investigating denosumab as an add-on treatment to neoadjuvant chemotherapy and two different nab-paclitaxel schedules in a 2x2 design in primary breast cancer - First results of the GeparX study

Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast Cancer: The GeparX 2 × 2 Randomized Clinical Trial

Abstract PO3-18-10: Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter WSG-ADAPTcycle trial (n=5,290)

Abstract LBO1-05: Impact of age and ovarian function suppression (OFS) on endocrine response to short preoperative endocrine therapy (ET): Results from the multicenter ADAPTcycle trial (n=4,334)

Abstract PO1-02-13: Germline mutation status of BRCA1/2 and other breast cancer predisposition genes as predictive and prognostic biomarker: Results of the GeparX study (GeparX-BRCA)

Suchergebnisse filtern